Trial intelligence / Profile preview

Megestrol vs LNG-IUS for Fertility-Sparing in Endometrial Hyperplasia and Cancer

NCT01943058Phase 2Withdrawn

Sponsor
University of Southern California
Start
Mar 2014
Primary completion
Oct 2016
Modality
Small Molecules
01

Overview

A Phase 2 trial of avatrombopag in endometrial hyperplasia (EH), endometrial cancer (EC), sponsored by University of Southern California. Planned start Mar 2014; status: withdrawn.

02

Drugs

avatrombopag
03

Conditions

endometrial hyperplasia (EH)endometrial cancer (EC)

Beyond the preview

Go deeper on NCT01943058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01943058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call